Alligator Bioscience AB (ATORX)

Stockholm
Currency in SEK
0.2235
-0.0055(-2.40%)
Real-time Data
ATORX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 9 days
Fair Value
Day's Range
0.22350.2360
52 wk Range
0.21551.5680
Key Statistics
Edit
Prev. Close
0.229
Open
0.2295
Day's Range
0.2235-0.236
52 wk Range
0.2155-1.568
Volume
517.52K
Average Volume (3m)
3.76M
1-Year Change
-80.85%
Book Value / Share
-0.1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATORX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Alligator Bioscience AB Company Profile

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Sweden. The company’s product portfolio includes Mitazalimab, a stimulatory antibody that targets CD40, which is in phase 2 clinical trial for the treatment of solid metastatic tumors, including pancreatic cancer; and ATOR-4066, tumor-directed bispecific antibody, developed using Neo-X-Prime technology platform for immunotherapy, which is in preclinical stage. It also offers ALG.APV-527, a bispecific antibody that targets the 4-1BB and 5T4 molecules, which is in phase 1 clinical trial for the treatment of solid metastatic tumors; and ATOR-1017, an immunostimulatory antibody, which is in phase 1 clinical trial for the treatment of metastatic cancer. In addition, the company develops products using its technology platforms, including ALLIGATOR-GOLD, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; ALLIGATOR-FAB, which is built on multiple scaffolds with optimal drug development properties to further increase the structural diversity of generated antibodies; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and RUBY, a bispecific antibody format. Further, it has collaboration and out-licensing agreements with Aptevo Therapeutics, Inc.; Orion Corporation.; MacroGenics, Inc.; Biotheus Inc.; BioArctic AB; and Abclon Inc. The company was founded in 2000 and is headquartered in Lund, Sweden.

Compare ATORX to Peers and Sector

Metrics to compare
ATORX
Peers
Sector
Relationship
P/E Ratio
−0.7x−3.0x−0.7x
PEG Ratio
−0.02−0.020.00
Price/Book
−2.3x2.2x2.6x
Price / LTM Sales
6.3x6.1x3.1x
Upside (Analyst Target)
-120.5%55.4%
Fair Value Upside
Unlock25.4%9.9%Unlock

People Also Watch

0.49
IMMNOV
-2.00%
3.4500
SIVEH
-1.43%
198.6000
BIOAb
-3.97%

FAQ

What Is the Alligator Bioscience (ATORX) Stock Price Today?

The Alligator Bioscience stock price today is 0.2235

What Stock Exchange Does Alligator Bioscience Trade On?

Alligator Bioscience is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Alligator Bioscience?

The stock symbol for Alligator Bioscience is "ATORX."

What Is the Alligator Bioscience Market Cap?

As of today, Alligator Bioscience market cap is 169.42M.

What is Alligator Bioscience Earnings Per Share?

The Alligator Bioscience EPS is -0.358.

What Is the Next Alligator Bioscience Earnings Date?

Alligator Bioscience will release its next earnings report on Jan 21, 2025.

From a Technical Analysis Perspective, Is ATORX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.